These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8267 related articles for article (PubMed ID: 2332102)

  • 1. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
    Surkis R; Rubinraut S; Dagan S; Tzehoval E; Fridkin M; Ben Yoseph R; Catane R
    Int J Biochem; 1990; 22(2):193-5. PubMed ID: 2332102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a new carrier for immunization: polytuftsin. Two examples of its use with peptides selected in the hepatitis B surface antigen.
    Trudelle Y; Brack A; Delmas A; Pedoussaut S; Rivaille P
    Int J Pept Protein Res; 1987 Jul; 30(1):54-60. PubMed ID: 3667078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40).
    Gokulan K; Khare S; Rao DN
    DNA Cell Biol; 1999 Aug; 18(8):623-30. PubMed ID: 10463058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
    Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
    J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polytuftsin: its possible effects and mechanism during macrophage activation.
    Dhawan P; Nath I; Rao DN
    Immunol Lett; 1995 May; 46(1-2):177-82. PubMed ID: 7590916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological investigations of new tuftsin analogs with elongated peptide chain.
    Konopinska D; Luczak M; Gumułka S
    Int J Pept Protein Res; 1983 Aug; 22(2):223-30. PubMed ID: 6311764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of human granulocyte phagocytosis stimulation by tuftsin.
    Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
    J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
    Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
    Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.
    Kubo S; Rodriguez T; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
    Hepatology; 1994 Apr; 19(4):1044-9. PubMed ID: 8138244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin.
    Titov VM; Meshcheryakova EA; Balashova TA; Andronova TM; Ivanov VT
    Int J Pept Protein Res; 1995 Apr; 45(4):348-55. PubMed ID: 7601608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of sterile saline solutions of synthetic tuftsin, a naturally occurring immunomodulating peptide.
    Nishioka K; Dessens SE; Rodriguez T
    Pept Res; 1991; 4(4):230-3. PubMed ID: 1823602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 414.